Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)

NCT00568594 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
176
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis